Results 41 to 50 of about 273,499 (304)
Pediatric Blood &Cancer, EarlyView.ABSTRACT In pediatric patients, T‐cell lymphoblastic lymphoma (T‐LBL) survival exceeds 80%. Relapse remains associated with limited curative options. Frontline treatment is largely extrapolated from T‐cell acute lymphoblastic leukemia (T‐ALL) treatment, reflecting the ongoing debate, whether both entities represent distinct diseases or variants within ...
Marie C. Heider +4 more
wiley +1 more source
An Evidence-Based Review of Fat Modifying Supplemental Weight Loss Products
Journal of Obesity, 2011 Objective. To review the literature on fat modifying dietary supplements commonly used for weight loss. Methods. Recently published randomized, placebo-controlled trials were identified in PubMed, MEDLINE, International Pharmaceutical Abstracts, Cochrane
Amy M. Egras +3 more
doaj +1 more source
Correction to: Abstracts from the NIHR INVOLVE Conference 2017
Research Involvement and Engagement, 2018 Correction After publication of this supplement [1], it was brought to our attention that errors were apparent in the following abstracts and are included in this correction.
Elspeth Mathie +11 more
doaj +1 more source
The World Before 1907: Searching for Chemical Literature before Chemical Abstracts. [PDF]
, 2006 An overview of early abstracting sources for historical chemical literature prior to the launch of Chemical Abstracts in 1907.UT ...
Flaxbart, David
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego +10 more
wiley +1 more source
Efficacy and safety of TDF/FTC-containing first-line HAART in clinical practice – 2-year data from the German Outpatient Cohort [PDF]
, 2008 Poster presentation: Purpose of the study First-line HAART with tenofovir DF (TDF) and FTC in pivotal trials has been associated with high efficacy and good tolerability.
Braun, Patrick +8 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley +1 more source
Proceedings of 2015 Aurora Scientific Day
Journal of Patient-Centered Research and Reviews, 2015 This supplement includes abstracts accepted to the 41st annual Aurora Scientific Day research symposium, held May 20, 2015, in Milwaukee, Wisconsin. Aurora Scientific Day provides a forum for research conducted by residents, fellows, students, teaching ...
Various
doaj +1 more source
Advances in Lasers for the Treatment of Stones-a Systematic Review [PDF]
, 2018 PURPOSE OF REVIEW: Laser lithotripsy is increasingly used worldwide and is a continuously evolving field with new and extensive research being published every year.
Kronenberg, P, Somani, B
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi +5 more
wiley +1 more source